JP2021534104A5 - - Google Patents

Info

Publication number
JP2021534104A5
JP2021534104A5 JP2021506660A JP2021506660A JP2021534104A5 JP 2021534104 A5 JP2021534104 A5 JP 2021534104A5 JP 2021506660 A JP2021506660 A JP 2021506660A JP 2021506660 A JP2021506660 A JP 2021506660A JP 2021534104 A5 JP2021534104 A5 JP 2021534104A5
Authority
JP
Japan
Prior art keywords
substituted
alkyl
independently selected
cycloalkyl
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021506660A
Other languages
English (en)
Japanese (ja)
Other versions
JP7434281B2 (ja
JP2021534104A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/045459 external-priority patent/WO2020033514A1/en
Publication of JP2021534104A publication Critical patent/JP2021534104A/ja
Publication of JP2021534104A5 publication Critical patent/JP2021534104A5/ja
Application granted granted Critical
Publication of JP7434281B2 publication Critical patent/JP7434281B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021506660A 2018-08-08 2019-08-07 Pad酵素のベンズイミダゾール阻害剤 Active JP7434281B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862715845P 2018-08-08 2018-08-08
US62/715,845 2018-08-08
PCT/US2019/045459 WO2020033514A1 (en) 2018-08-08 2019-08-07 Benzimidazole inhibitors of pad enzymes

Publications (3)

Publication Number Publication Date
JP2021534104A JP2021534104A (ja) 2021-12-09
JP2021534104A5 true JP2021534104A5 (cg-RX-API-DMAC10.html) 2022-08-16
JP7434281B2 JP7434281B2 (ja) 2024-02-20

Family

ID=67766305

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021506660A Active JP7434281B2 (ja) 2018-08-08 2019-08-07 Pad酵素のベンズイミダゾール阻害剤

Country Status (7)

Country Link
US (1) US12692254B2 (cg-RX-API-DMAC10.html)
EP (1) EP3833439B1 (cg-RX-API-DMAC10.html)
JP (1) JP7434281B2 (cg-RX-API-DMAC10.html)
KR (1) KR20210042933A (cg-RX-API-DMAC10.html)
CN (1) CN112789087B (cg-RX-API-DMAC10.html)
ES (1) ES2956090T3 (cg-RX-API-DMAC10.html)
WO (1) WO2020033514A1 (cg-RX-API-DMAC10.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3833440A1 (en) 2018-08-08 2021-06-16 Bristol-Myers Squibb Company Indole and azaindole inhibitors of pad enzymes
ES2929200T3 (es) 2018-08-08 2022-11-25 Bristol Myers Squibb Co Tienopirroles sustituidos como inhibidores de PAD4
ES2956090T3 (es) 2018-08-08 2023-12-13 Bristol Myers Squibb Co Inhibidores de bencimidazol de enzimas PAD
CN115298175B (zh) 2020-02-06 2024-05-07 百时美施贵宝公司 可用作免疫抑制剂的大环pad4抑制剂
TW202140477A (zh) 2020-02-12 2021-11-01 美商必治妥美雅史谷比公司 雜環pad4抑制劑
MX2022013615A (es) 2020-04-30 2022-11-16 Gilead Sciences Inc Inhibidores de macrociclo de peptidilarginina deiminasas.
EP4267562A1 (en) 2020-12-22 2023-11-01 Gilead Sciences, Inc. Inhibitors of peptidylarginine deiminases
TW202233174A (zh) 2020-12-22 2022-09-01 美商基利科學股份有限公司 肽基精胺酸去亞胺酶之抑制劑
WO2025024265A1 (en) 2023-07-21 2025-01-30 Bristol-Myers Squibb Company Methods of assessing citrullination and activity of pad4 modulators
WO2026020127A2 (en) 2024-07-19 2026-01-22 Bristol-Myers Squibb Company Methods of assessing citrullination and activity of pad2 modulators

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1214330A1 (en) 1999-09-21 2002-06-19 LION Bioscience AG Benzimidazole derivatives and combinatorial libraries thereof
US8470819B2 (en) * 2008-11-03 2013-06-25 Merck Sharp & Dohme Corp. Benzimidazole and aza-benzimidazole carboxamides
RU2611010C2 (ru) * 2012-07-26 2017-02-17 Глаксо Груп Лимитед 2-(Азаиндол-2-ил)бензимидазолы в качестве ингибиторов PAD4
WO2016185279A1 (en) * 2015-05-21 2016-11-24 Glaxosmithkline Intellectual Property Development Limited Benzoimidazole derivatives as pad4 inhibitors
AR107030A1 (es) 2015-12-09 2018-03-14 Padlock Therapeutics Inc Inhibidores aza-bencimidazol de pad4
AR107032A1 (es) * 2015-12-09 2018-03-14 Padlock Therapeutics Inc Inhibidores bicíclicos de pad4
CN108602812B (zh) 2015-12-22 2021-11-02 坎塞拉有限公司 可用作哺乳动物组蛋白去乙酰化酶活性的抑制剂的双环异羟肟酸类化合物
SG11201807021UA (en) 2016-02-23 2018-09-27 Padlock Therapeutics Inc Heteroaryl inhibitors of pad4
US10703741B2 (en) * 2016-07-27 2020-07-07 Padlock Therapeutics, Inc. Covalent inhibitors of PAD4
KR102502992B1 (ko) 2016-09-12 2023-02-24 패들락 테라퓨틱스, 인코포레이티드 Pad4의 헤테로아릴 억제제
CN107311933B (zh) * 2017-06-28 2020-12-22 中国人民解放军军事医学科学院毒物药物研究所 一类苯并咪唑衍生物,及其制备方法和用途
JP7311228B2 (ja) 2017-06-30 2023-07-19 ベイジン タイド ファーマシューティカル カンパニー リミテッド Rho-関連プロテインキナーゼ阻害剤、それを含む医薬組成物並びにその調製方法及び使用
CN111225915B (zh) 2017-10-18 2023-03-07 朱比兰特埃皮帕德有限公司 作为pad抑制剂的咪唑并吡啶化合物
ES2929200T3 (es) 2018-08-08 2022-11-25 Bristol Myers Squibb Co Tienopirroles sustituidos como inhibidores de PAD4
MX2021001471A (es) 2018-08-08 2021-04-28 Bristol Myers Squibb Co Benzimidazoles sustituidos como inhibidores de peptidil arginina deiminasa 4 (pad4).
EP3833440A1 (en) 2018-08-08 2021-06-16 Bristol-Myers Squibb Company Indole and azaindole inhibitors of pad enzymes
ES2956090T3 (es) 2018-08-08 2023-12-13 Bristol Myers Squibb Co Inhibidores de bencimidazol de enzimas PAD

Similar Documents

Publication Publication Date Title
JP2021534108A5 (cg-RX-API-DMAC10.html)
JP2021534097A5 (cg-RX-API-DMAC10.html)
JP2023512557A5 (cg-RX-API-DMAC10.html)
JP2023500611A5 (cg-RX-API-DMAC10.html)
RU2015122757A (ru) Бициклические соединения мочевины, тиомочевины, гуанидина и цианогуанидина, пригодные для лечения боли
JP2011079828A5 (cg-RX-API-DMAC10.html)
JP2021532109A5 (cg-RX-API-DMAC10.html)
JP2023509422A5 (cg-RX-API-DMAC10.html)
JP2013504593A5 (cg-RX-API-DMAC10.html)
JP2011520906A5 (cg-RX-API-DMAC10.html)
RU2001117757A (ru) Замещенные бензимидазолы и их применение в качестве ингибиторов поли(аденозиндифосфатрибоза)полимеразы
JP2012505235A5 (cg-RX-API-DMAC10.html)
JP2005538072A5 (cg-RX-API-DMAC10.html)
CA2615022A1 (en) Hcv ns3 protease inhibitors
JP2022526220A5 (cg-RX-API-DMAC10.html)
JP2011511095A5 (cg-RX-API-DMAC10.html)
JP2014524441A5 (cg-RX-API-DMAC10.html)
JP2018524403A5 (cg-RX-API-DMAC10.html)
JP2010504346A5 (cg-RX-API-DMAC10.html)
JP2023526248A5 (cg-RX-API-DMAC10.html)
JP2012508252A5 (cg-RX-API-DMAC10.html)
JP2020517707A5 (cg-RX-API-DMAC10.html)
JP2009538897A5 (cg-RX-API-DMAC10.html)
JP2017509689A5 (cg-RX-API-DMAC10.html)
JP2011521911A5 (cg-RX-API-DMAC10.html)